DOCS
Doximity, Inc.
NYSE · Healthcare · Medical - Healthcare Information Services · US
$31.45
+1.55%Year over year
Reported trailing growth
- Revenue
- +11.2%
- EBITDA
- -9.9%
- EBIT
- -17.9%
- EPS
- -28.8%
- Free cash flow
- +4.2%
- Operating cash flow
- +4.2%
Forward estimates
Based on analyst estimates
- Revenue
- +6.4%
- EBITDA
- +43.7%
- EPS
- +66.8%
Three-year CAGR
- Revenue
- +15.5%
- EBITDA
- +22.6%
- EBIT
- +19.8%
- Net income
- +20.2%
- EPS
- +21.9%
- Free cash flow
- +22.3%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026